Bioparox (fusafungine) spray: new contra-indications and recommendations to minimize the risk of serious allergic reactions

Information for healthcare professionals,

Scientific Centre of drug and medical technology expertise after academician E. Gabrielyan on behalf of drug safety monitoring brings to the healthcare professional’s attention the information letter of the pharmaceutical company “Les Laboratoir Servier” about the new safety information of the medicinal product Bioparox (fusafungin).

 
Download this file (Bioparox_Servier_eng.pdf)Download[24.08.2015]